Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
Sunnybrook Health Sciences Centre
University of Ulm
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
University of Ulm
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Peking Union Medical College Hospital
University College, London
Institute of Hematology & Blood Diseases Hospital, China
University of Ulm
University College, London
Kosin University Gospel Hospital
Shanghai Changzheng Hospital
University of Nebraska
Abramson Cancer Center at Penn Medicine
Brown University
Hackensack Meridian Health
M.D. Anderson Cancer Center
University College, London
University of Athens
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
University of Washington
University of Arizona
Alliance for Clinical Trials in Oncology
Swiss Cancer Institute
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
German CLL Study Group
University of Washington
Fred Hutchinson Cancer Center